India Proposes Faster Medical Device Approvals Under Medical Devices Rules 2017

India’s Ministry of Health and Family Welfare has proposed amendments to the Medical Devices Rules, 2017, aimed at accelerating the licensing process for manufacturers. The draft notification, released in the official gazette, seeks to reduce approval timelines across device categories.

The move is intended to improve regulatory efficiency while maintaining safety and quality standards. The proposal is currently open for public consultation before final implementation.

Medical Device Rules 2017 Amendment

The draft amendments focus on revising approval timelines and streamlining regulatory procedures. Authorities have proposed reducing the time required to grant manufacturing licences across all device categories.

The framework retains the existing classification system based on risk levels while improving processing efficiency. The changes also aim to bring greater predictability and transparency to the approval process.

Medical Device Approval Timeline Reduction by Risk Category

Medical devices in India are classified into four categories, ranging from low-risk to high-risk products. The proposed amendments introduce shorter approval timelines for both ends of the spectrum.

• Low-risk devices (e.g., blood pressure monitors, pulse oximeters): reduced from 140 days to 115 days
• High-risk devices (e.g., cardiac stents, joint implants): reduced from 105 days to 90 days

Stages Of Licensing Process and Transparency Measures

The draft notification outlines defined timelines for each stage of the licensing process. These stages include application review, inspection, and compliance verification by regulatory authorities.

Officials stated that setting clear timelines will minimise delays and improve accountability in approvals. The objective is to create a more structured and transparent framework for both regulators and manufacturers.

Impact On Medical Device Industry and Domestic Manufacturing

The proposed amendments are expected to benefit manufacturers by reducing time-to-market for medical devices. Faster approvals could support innovation and help companies respond to evolving healthcare demands.

The move also aligns with broader efforts to strengthen domestic manufacturing capabilities in the healthcare sector. Improved regulatory efficiency may further enhance India’s position in the global medical device market.

Read More: India's Outward FDI Commitments Fall Nearly 49% to $4.49 Billion.

Track the stock market trends in Hindi. Visit Angel One News for the latest market trends, insights, and share market news in Hindi.

Conclusion

The proposed amendments to the Medical Devices Rules, 2017 aim to streamline licensing procedures and reduce approval timelines. By introducing defined timelines and simplifying processes, the government seeks to improve regulatory efficiency.

The changes cover multiple device categories while maintaining safety and quality standards. The draft remains open for public feedback before it is finalised and implemented.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.